Details for 2015724070

Up to date per 10.04.2026

Actions

Title / Product Name

BELIMUMAB FORMULIERUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015724070

EP Publication Number

3143047

E-Number

1505508

Language

PCT Number

IB15053602

Publication Date

22.03.2017 A

20.07.2022 B1

Registration Date

20.07.2022

AT Publication Date

15.08.2022

Application Date

15.05.2015

Registration Number

Priorities

16.05.2014

201461994427 P

18.12.2014

201462093734 P

22.12.2014

201462095181 P

IPC

C07K 16/28 20060101AFI20151124BHEP

Maximum Duration of Protection

15.05.2035

Owner

GlaxoSmithKline Intellectual Property Management LimitedGSK Medicines Research Centre, Gunnels Wood Road Stevenage, SG1 2NYGB

GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED980 Great West Road Brentford, Middlesex TW8 9GSGB

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße1010 WienAT

Inventor

BLAKE-HASKINS, AngelaOne Medimmune Way Gaithersburg, Maryland 20878US

MARSHALL, Tristan14200 Shady Grove Road Rockville, Maryland 20850US

O'BERRY, KristenOne Medimmune Way Gaithersburg, Maryland 20878US

PERKINS, Melissa D.1776 Centennial Drive McPherson, Kansas 67460US

Information about Fees